Satish K Garg,Emma Mason,Drew C Renner et al.
Satish K Garg et al.
Moshe Phillip,Tadej Battelino
Moshe Phillip
Torben Biester,Julia K Mader,Lutz Heinemann
Torben Biester
Rayhan Lal,Lalantha Leelarathna
Rayhan Lal
Jennifer L Sherr,Bruce W Bode,Tadej Battelino et al.
Jennifer L Sherr et al.
Michael C Riddell,Lauren V Turner,Dessi P Zaharieva
Michael C Riddell
Extended Use of Automated Insulin Delivery in Young People with Type 1 Diabetes and Elevated HbA1c: 52-Week Outcomes of the CO-PILOT Trial [0.03%]
青年1型糖尿病患者在HbA1c升高的情况下使用自动化胰岛素输送系统的扩展研究：CO-PILOT试验的52周结局
Marcus C Ward,Alisa Boucsein,Yongwen Zhou et al.
Marcus C Ward et al.
Aims: To assess longer term outcomes of automated insulin delivery (AID) in young people (7-25 years) with type 1 diabetes (T1D) and baseline glycated hemoglobin (HbA1c) ≥ 69 mmol/mol (8.5%). ...
Impact of Continuous Glucose Monitor on Health Care Resource Utilization in Adults with Type 2 Diabetes Managed by Noninsulin Therapies [0.03%]
持续葡萄糖监测对非胰岛素治疗的2型糖尿病成人医疗资源利用率的影响
Anup K Sharma,Abraham Lee,Shivani Mehta et al.
Anup K Sharma et al.
Background: Daily use of continuous glucose monitoring (CGM) has been shown to reduce diabetes-related events and associated costs in individuals with type 2 diabetes (T2D) regardless of their therapy. However, adoption o...
Optimizing Diabetes Management During Type 1 Diabetes Pregnancy with Automated Insulin Delivery Therapy: Clinical Impact and Economic Consequences in Spain [0.03%]
自动化胰岛素输送疗法在西班牙1型糖尿病妊娠期血糖管理中的临床效益和经济影响分析
Pilar I Beato-Víbora,Maria-Eleni Syleouni,Tara T M Lee et al.
Pilar I Beato-Víbora et al.
Background and aim: The CamAPS FX automated insulin delivery (AID) system is extensively evaluated and uniquely tailored for T1D pregnancies. This study evaluated the clinical and economic implications of improving glycem...